Pathophysiology of diabetes mellitus in Cushing's syndrome.
about
Endocrine causes of nonalcoholic fatty liver diseaseComorbidities in Cushing's diseaseThe Treatment of Cushing's Disease.The Metabolic Implications of Glucocorticoids in a High-Fat Diet Setting and the Counter-Effects of ExerciseHypothesis of the neuroendocrine cortisol pathway gene role in the comorbidity of depression, type 2 diabetes, and metabolic syndrome.Extended treatment of Cushing's disease with pasireotide: results from a 2-year, Phase II study.Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy.Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasiaThe hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications.Neuropsychiatric disorders in Cushing's syndromeCushing's syndrome: epidemiology and developments in disease management.Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation.Regulation of corticoid and serotonin receptor brain system following early life exposure of glucocorticoids: long term implications for the neurobiology of mood.Sustained weight loss in patients treated with mifepristone for Cushing's syndrome: a follow-up analysis of the SEISMIC study and long-term extensionAngiopoietin-like 4 (Angptl4) protein is a physiological mediator of intracellular lipolysis in murine adipocytes.Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11β-hydroxysteroid dehydrogenase 1Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells.Hepatic ALT isoenzymes are elevated in gluconeogenic conditions including diabetes and suppressed by insulin at the protein levelGlucocorticoids and type 2 diabetes: from physiology to pathologyAngiopoietin-like 4 (Angptl4): A glucocorticoid-dependent gatekeeper of fatty acid flux during fasting.Transcriptional regulation of FoxO3 gene by glucocorticoids in murine myotubes.Low-dose dexamethasone administration for 3 weeks favorably affects plasma HDL concentration and composition but does not affect very low-density lipoprotein kinetics.Pathogenesis of hepatic steatosis: the link between hypercortisolism and non-alcoholic fatty liver disease.Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations.Glucose metabolism in patients with subclinical Cushing's syndrome.Advances in the epidemiology, pathogenesis, and management of Cushing's syndrome complications.Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome.Influence of glucocorticoids and growth hormone on insulin sensitivity in humans.Metabolic functions of glucocorticoid receptor in skeletal muscle.Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events.Italian Society for the Study of Diabetes (SID)/Italian Endocrinological Society (SIE) guidelines on the treatment of hyperglycemia in Cushing's syndrome and acromegaly.Cushing's disease: the burden of illness.Concomitant alterations of metabolic parameters, cardiovascular risk factors and altered cortisol secretion in patients with adrenal incidentalomas during prolonged follow-up.Coumarins as potential antidiabetic agents.The Eosinophil Count Tends to Be Negatively Associated with Levels of Serum Glucose in Patients with Adrenal Cushing Syndrome.Improvement in insulin sensitivity during mifepristone treatment of Cushing syndrome: early and late effects.Copeptin and insulin resistance: effect modification by age and 11 β-HSD2 activity in a population-based study.Antidepressant-like effect of simvastatin in diabetic rats.Invasive aspergillosis in a putty-nosed monkey (Cercopithecus nictitans) with adrenocortical Cushing's syndrome.Dysregulation of Δ4-3-oxosteroid 5β-reductase in diabetic patients: Implications and mechanisms.
P2860
Q26780254-299AE632-A456-4F18-A51C-6F0FE9E61362Q27010491-5079C799-25E7-4A36-B6C1-FA4DE6897306Q27010590-64E76407-4244-43CE-9DDE-297B951CF3B4Q28076700-78974926-9D95-4EA8-9D10-AAC550A50213Q33575333-A66C34AA-1C5E-4816-8A24-C3C46B8194D0Q33858344-CF1BCF5E-6E1C-49A9-9E4C-14D5F2354968Q33944314-D7CA68A9-C0B6-4576-AF26-D15487A68FF7Q34431162-CA0CB845-B139-4775-A06F-B3C530237165Q35126105-2CB07CA0-7873-4586-846D-6D4CE78BC969Q35487292-C08CC6B9-7642-4B08-975F-814A14BE7DBEQ35531889-85F1F058-FBC5-49CF-9DC6-7537ACB3BDA4Q35720799-6CC81ABA-984A-4D87-B960-7B5383D41AF6Q35740275-D0ED1C01-4251-4550-AF21-05AC75F0EC65Q35823679-505A98C1-4209-4963-9168-E9BBCF97C49AQ35868142-7FE3C9EF-C877-4D3C-9695-877BE82F5320Q35902915-25C472DE-4835-4438-AD2F-5E3B1204CE6EQ35931243-00C068BF-7E3E-44CF-8542-562021C183EFQ36417711-DE7ECB7C-1368-4232-B3C4-1E5F5D5821F3Q36506631-41D8F82D-26FE-41C1-96C8-66225A4B5E9CQ36719119-1BD239D3-C20E-4C45-9C81-2527CF7EB35FQ36775635-AA05BBA1-1463-4D52-8742-A442C39FA6F8Q36802963-BB4FC91B-03B6-4B2D-BBED-914059448644Q37266370-491E715F-FE4D-4678-9EEA-297BB2DEDDD1Q37617500-0B2562AB-4E43-4E54-BF37-75BBBFDA8848Q37990759-8D93A7DC-3797-4F9F-913F-D2F46FF9C0CFQ38015162-D246C906-3032-4308-8AD2-3F8EFCC87211Q38085698-801BB698-FB12-4949-900F-329871A98341Q38091130-55E20765-B107-48D5-ACF3-84B20143ECA7Q38092488-4D50833E-F1EB-4415-A2D8-CDBD9018E504Q38247488-74ED3773-EB37-422A-87CA-B58E237B1246Q38683309-22512F47-74DC-4822-A8F7-A2CBA83B77E6Q38836721-1FB79A42-203F-4030-A0DD-8E1F7713F594Q39088498-7394E64C-C664-4816-9AFB-52BDC4885AB7Q39413318-9A1A1F5C-2A13-426A-9932-B178C00FCF62Q42366429-6EE43F72-646B-4B51-9FDC-3D66D809A624Q42561171-74B5539F-2436-478D-9239-00D479579FC7Q47319650-526A5F41-8012-4C77-806A-76DC081AE0D3Q48079263-A4E353C0-94D9-4459-9B6C-BD215F91DE27Q48608091-3A0D7355-62B6-49FD-9835-BFC75A1A5A8CQ50099673-72DE23A5-7DB0-4FB2-BEE5-64F58671404F
P2860
Pathophysiology of diabetes mellitus in Cushing's syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathophysiology of diabetes mellitus in Cushing's syndrome.
@en
Pathophysiology of diabetes mellitus in Cushing's syndrome.
@nl
type
label
Pathophysiology of diabetes mellitus in Cushing's syndrome.
@en
Pathophysiology of diabetes mellitus in Cushing's syndrome.
@nl
prefLabel
Pathophysiology of diabetes mellitus in Cushing's syndrome.
@en
Pathophysiology of diabetes mellitus in Cushing's syndrome.
@nl
P2093
P50
P356
P1433
P1476
Pathophysiology of diabetes mellitus in Cushing's syndrome.
@en
P2093
Alessia Cozzolino
Chiara Simeoli
Maria Cristina De Martino
Monica De Leo
Pasquale Vitale
P356
10.1159/000314319
P478
92 Suppl 1
P577
2010-09-10T00:00:00Z